Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Acquires ID Labs

NEW YORK (GenomeWeb) – Empire Genomics said on Monday that it has acquired molecular diagnostic reagents firm ID Labs for an undisclosed amount.

Based in London, Ontario, ID Labs provides antibodies, molecular probes, cytogenetics media, and other molecular biology reagents to academia, government, pharmaceutical, biotech, and hospital customers.

Empire Genomics CEO Anthony Johnson said that the deal is aligned "with our corporate strategy of complementing the product offerings for our clinical lab and customers, as well as increasing our global distribution network." He added that he expects it to be the first of several acquisitions "as we look to accelerate the growth of our business in the ever changing molecular diagnostics environment." 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.